BiomX Inc. – AMEX:PHGE
BiomX stock price today
$0.52
-0.22
-30.29%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 3 days
BiomX stock price monthly change
+119.12%
month
BiomX stock price quarterly change
+119.12%
quarter
BiomX stock price yearly change
+140.32%
year
BiomX key metrics
Market Cap | 11.28M |
Enterprise value | N/A |
P/E | -0.3 |
EV/Sales | N/A |
EV/EBITDA | 0.41 |
Price/Sales | N/A |
Price/Book | 0.37 |
PEG ratio | N/A |
EPS | -0.52 |
Revenue | -354K |
EBITDA | -17.65M |
Income | -29.61M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | 4987.57% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeBiomX stock price history
BiomX stock forecast
BiomX financial statements
Average Price Target
$2
Potential upside: 284.91%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | -90K | -6.41M | 7123.33% |
|---|---|---|---|
| Sep 2023 | -89K | -382K | 429.21% |
| Dec 2023 | -87K | -5.49M | 6311.49% |
| Mar 2024 | -88K | -17.32M | 19689.77% |
| Jun 2023 | 41253000 | 25.38M | 61.54% |
|---|---|---|---|
| Sep 2023 | 33056000 | 24.90M | 75.33% |
| Dec 2023 | 58156000 | 55.07M | 94.7% |
| Mar 2024 | 81606000 | 58.73M | 71.97% |
| Jun 2023 | -4.07M | -1K | 4.48M |
|---|---|---|---|
| Sep 2023 | -5.92M | -32K | -1.30M |
| Dec 2023 | -6.24M | -6K | -1.32M |
| Mar 2024 | -11.35M | 663K | 38.97M |
BiomX alternative data
| Aug 2023 | 54 |
|---|---|
| Sep 2023 | 54 |
| Oct 2023 | 54 |
| Nov 2023 | 54 |
| Dec 2023 | 54 |
| Jan 2024 | 54 |
| Feb 2024 | 54 |
| Mar 2024 | 54 |
| Apr 2024 | 54 |
| May 2024 | 58 |
| Jun 2024 | 58 |
| Jul 2024 | 58 |
BiomX other data
9.47%
-11.13%
of PHGE is owned by hedge funds
2.82M
-3.33M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| May 2023 | 10914 | 0 |
| Nov 2023 | 0 | 10914 |
| Mar 2024 | 2167827 | 0 |
| Quarter | Transcript |
|---|---|
| Q1 2024 21 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 3 Apr 2024 | Q4 2023 Earnings Call Transcript |
| Q2 2023 9 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Q1 2023 15 May 2023 | Q1 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Mr. Jonathan Eitan Solomon MBA (1977) Chief Executive Officer & Director | $564,250 |
| Dr. Merav Bassan Ph.D. (1966) Chief Devel. Officer | $410,870 |
-
What's the price of BiomX stock today?
One share of BiomX stock can currently be purchased for approximately $0.52.
-
When is BiomX's next earnings date?
Unfortunately, BiomX's (PHGE) next earnings date is currently unknown.
-
Does BiomX pay dividends?
No, BiomX does not pay dividends.
-
How much money does BiomX make?
BiomX has a market capitalization of 11.28M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 166.42% to -357K US dollars.
-
What is BiomX's stock symbol?
BiomX Inc. is traded on the AMEX under the ticker symbol "PHGE".
-
What is BiomX's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of BiomX?
Shares of BiomX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are BiomX's key executives?
BiomX's management team includes the following people:
- Mr. Jonathan Eitan Solomon MBA Chief Executive Officer & Director(age: 48, pay: $564,250)
- Dr. Merav Bassan Ph.D. Chief Devel. Officer(age: 59, pay: $410,870)
-
How many employees does BiomX have?
As Jul 2024, BiomX employs 58 workers, which is 7% more then previous quarter.
-
When BiomX went public?
BiomX Inc. is publicly traded company for more then 6 years since IPO on 13 Mar 2019.
-
What is BiomX's official website?
The official website for BiomX is biomx.com.
-
How can i contact BiomX?
BiomX can be reached via phone at +972 72 394 2377.
-
What is BiomX stock forecast & price target?
Based on 1 Wall Street analysts` predicted price targets for BiomX in the last 12 months, the avarage price target is $2. The average price target represents a 284.91% change from the last price of $0.52.
BiomX company profile:
BiomX Inc.
biomx.comExchange:
AMEX
Full time employees:
58
Industry:
Biotechnology
Sector:
Healthcare
BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC). It is developing BX004, a phage therapy for CF patients with chronic Pseudomonas aeruginosa respiratory infections that is in Phase 1b/2a clinical trials. The company's pipeline products also include BX005, a topical phage cocktail, which is in Phase 1/2 clinical study that targets Staphylococcus aureus (S. aureus), a bacteria associated with the manifestation of the disease; and BX003, an orally administered phage cocktail, which is in Phase 1b/2a that targets a bacterial target present in the gut of IBD and PSC patients. In addition, the company engages in the provision of colorectal cancer program that utilizes engineered phage with various payloads, which are administered intravenously to target Fusobacterium nucleatum bacteria residing within the tumor microenvironment. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
22 Einstein Street
Ness Ziona, 7414003
Ness Ziona, 7414003
CIK: 0001739174
ISIN: US09090D1037
CUSIP: 09090D103
